Back to results
US 2026/0092326 A1Published application
Circulating serum microrna biomarkers and methods for alzheimer's disease diagnosis
AssigneeSt. John’s University
InventorsSimon Geir Möller, Ketan Shirish Patil, Guido Werner Alves
Life of this patent
Estimating the term…
Abstract
Biomarkers and methods for identifying, verifying and confirming circulating serum-based microRNAs. The microRNAs (PARKmiRs) can be used to differentiate patient's suffering from Alzheimer's disease (AD) from non-AD patients.
Claims35
1-51. (canceled)
A method, comprising the steps of:
- (a) providing a plasma sample from a human patient;
- (b) detecting levels of SEQ ID NO:
- 22 and SEQ ID NO:
- 77 in the plasma sample;
- (c) diagnosing the human patient with Alzheimer's disease when the levels of SEQ ID NO:
- 22 and SEQ ID NO:
- 77 in the plasma sample are decreased in comparison to the levels of SEQ ID NO:
- 22 and SEQ ID NO:
- 77 in control plasma samples obtained from healthy patients;
- and
- (d) administering a cholinesterase inhibitor or an N-methyl-D-aspartate receptor antagonist to said human patient diagnosed with Alzheimer's disease.
8 more elements
Dependencies are inferred from the claim text.